Grant Pickering
Founder chez VAXCYTE, INC.
Fortune : 53 M $ au 31/03/2024
Profil
Grant E.
Pickering is the founder of Vaxcyte, Inc. (founded in 2013) where he holds the title of Chief Executive Officer & Director.
He is currently working as an Independent Director at Athira Pharma, Inc. since 2022.
Mr. Pickering's former positions include being the President, Chief Executive Officer & Director at Mymetics Corp.
in 2012, President, Chief Executive Officer & Director at Juvaris BioTherapeutics, Inc., and Senior Vice President-Operations at Dendreon Corp.
Mr. Pickering completed his undergraduate degree at The Pennsylvania State University in 1989 and obtained an MBA from Georgetown University in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VAXCYTE, INC.
0,71% | 01/04/2024 | 772 571 ( 0,71% ) | 53 M $ | 31/03/2024 |
ATHIRA PHARMA, INC.
0,07% | 19/05/2023 | 25 783 ( 0,07% ) | 70 645 $ | 31/03/2024 |
Postes actifs de Grant Pickering
| Sociétés | Poste | Début |
|---|---|---|
| VAXCYTE, INC. | Founder | 27/05/2013 |
| ATHIRA PHARMA, INC. | Director/Board Member | 27/01/2022 |
Anciens postes connus de Grant Pickering
| Sociétés | Poste | Fin |
|---|---|---|
| MYMETICS CORPORATION | Chief Executive Officer | 19/11/2012 |
| DENDREON CORPORATION | Chief Operating Officer | 18/11/2005 |
Juvaris BioTherapeutics, Inc.
 Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Chief Executive Officer | - |
Formation de Grant Pickering
| The Pennsylvania State University | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MYMETICS CORPORATION | Health Technology |
| ATHIRA PHARMA, INC. | Health Technology |
| VAXCYTE, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Juvaris BioTherapeutics, Inc.
Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Health Technology |
